210 related articles for article (PubMed ID: 30344927)
1. Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity.
Morimoto S; Fujiki F; Kondo K; Nakajima H; Kobayashi Y; Inatome M; Aoyama N; Nishida Y; Tsuboi A; Oka Y; Nishida S; Nakata J; Hosen N; Oji Y; Sugiyama H
Oncotarget; 2018 Sep; 9(75):34132-34141. PubMed ID: 30344927
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a novel NFAT-GFP reporter platform useful for the functional avidity maturation of HLA class II-restricted TCRs.
Fujiki F; Morimoto S; Nishida Y; Tanii S; Aoyama N; Inatome M; Inoue K; Katsuhara A; Nakajima H; Nakata J; Nishida S; Tsuboi A; Oka Y; Oji Y; Sogo S; Sugiyama H
Cancer Immunol Immunother; 2023 Jul; 72(7):2347-2356. PubMed ID: 36939853
[TBL] [Abstract][Full Text] [Related]
3. An Essential Role of the Avidity of T-Cell Receptor in Differentiation of Self-Antigen-reactive CD8+ T Cells.
Kondo K; Fujiki F; Nakajima H; Yatsukawa E; Morimoto S; Tatsumi N; Nishida S; Nakata J; Oka Y; Tsuboi A; Hosen N; Oji Y; Sugiyama H
J Immunother; 2016 Apr; 39(3):127-39. PubMed ID: 26938946
[TBL] [Abstract][Full Text] [Related]
4. Rapid Assessment of Functional Avidity of Tumor-Specific T Cell Receptors Using an Antigen-Presenting Tumor Cell Line Electroporated with Full-Length Tumor Antigen mRNA.
Campillo-Davo D; Versteven M; Roex G; Reu H; Heijden SV; Anguille S; Berneman ZN; Tendeloo VFIV; Lion E
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31972992
[TBL] [Abstract][Full Text] [Related]
5. Transduction of a novel HLA-DRB1*04:05-restricted, WT1-specific TCR gene into human CD4+ T cells confers killing activity against human leukemia cells.
Katsuhara A; Fujiki F; Aoyama N; Tanii S; Morimoto S; Oka Y; Tsuboi A; Nakajima H; Kondo K; Tatsumi N; Nakata J; Nakae Y; Takashima S; Nishida S; Hosen N; Sogo S; Oji Y; Sugiyama H
Anticancer Res; 2015 Mar; 35(3):1251-61. PubMed ID: 25750272
[TBL] [Abstract][Full Text] [Related]
6. HLA-DPB1*05: 01-restricted WT1332-specific TCR-transduced CD4+ T lymphocytes display a helper activity for WT1-specific CTL induction and a cytotoxicity against leukemia cells.
Lin Y; Fujiki F; Katsuhara A; Oka Y; Tsuboi A; Aoyama N; Tanii S; Nakajima H; Tatsumi N; Morimoto S; Tamanaka T; Tachino S; Hosen N; Nishida S; Oji Y; Kumanogoh A; Sugiyama H
J Immunother; 2013 Apr; 36(3):159-70. PubMed ID: 23502763
[TBL] [Abstract][Full Text] [Related]
7. Avidity characterization of genetically engineered T-cells with novel and established approaches.
Hillerdal V; Boura VF; Björkelund H; Andersson K; Essand M
BMC Immunol; 2016 Jul; 17(1):23. PubMed ID: 27411667
[TBL] [Abstract][Full Text] [Related]
8. Natural high-avidity T-cell receptor efficiently mediates regression of cancer/testis antigen 83 positive common solid cancers.
Li Q; Hu W; Liao B; Song C; Li L
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35798537
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function.
Ruggiero E; Carnevale E; Prodeus A; Magnani ZI; Camisa B; Merelli I; Politano C; Stasi L; Potenza A; Cianciotti BC; Manfredi F; Di Bono M; Vago L; Tassara M; Mastaglio S; Ponzoni M; Sanvito F; Liu D; Balwani I; Galli R; Genua M; Ostuni R; Doglio M; O'Connell D; Dutta I; Yazinski SA; McKee M; Arredouani MS; Schultes B; Ciceri F; Bonini C
Sci Transl Med; 2022 Feb; 14(631):eabg8027. PubMed ID: 35138911
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a stable T lymphoma cell line transduced with HLA-A*24:02-restricted WT1-specific TCR genes and its application to antigen-specific immunomonitoring.
Watanabe K; Toji S; Ohtake J; Nakano K; Satoh T; Kitamura H; Nishimura T
Biomed Res; 2013 Feb; 34(1):41-50. PubMed ID: 23428979
[TBL] [Abstract][Full Text] [Related]
11. Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.
Moore TV; Lyons GE; Brasic N; Roszkowski JJ; Voelkl S; Mackensen A; Kast WM; Le Poole IC; Nishimura MI
Cancer Immunol Immunother; 2009 May; 58(5):719-28. PubMed ID: 18836717
[TBL] [Abstract][Full Text] [Related]
12. Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.
Okamoto S; Mineno J; Ikeda H; Fujiwara H; Yasukawa M; Shiku H; Kato I
Cancer Res; 2009 Dec; 69(23):9003-11. PubMed ID: 19903853
[TBL] [Abstract][Full Text] [Related]
13. TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidity.
Pasetto A; Frelin L; Aleman S; Holmström F; Brass A; Ahlén G; Brenndörfer ED; Lohmann V; Bartenschlager R; Sällberg M; Bertoletti A; Chen M
J Immunol; 2012 Nov; 189(9):4510-9. PubMed ID: 23024278
[TBL] [Abstract][Full Text] [Related]
14. [Cytotoxicity of T cells transduced with WT1 peptide-specific T-cell receptor gene against human lung cancer cells in vitro].
An J; Cai SW; Li Y; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Aug; 34(9):1319-23. PubMed ID: 25263367
[TBL] [Abstract][Full Text] [Related]
15. Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain.
Kuball J; Hauptrock B; Malina V; Antunes E; Voss RH; Wolfl M; Strong R; Theobald M; Greenberg PD
J Exp Med; 2009 Feb; 206(2):463-75. PubMed ID: 19171765
[TBL] [Abstract][Full Text] [Related]
16. Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity/avidity thresholds.
Oren R; Hod-Marco M; Haus-Cohen M; Thomas S; Blat D; Duvshani N; Denkberg G; Elbaz Y; Benchetrit F; Eshhar Z; Stauss H; Reiter Y
J Immunol; 2014 Dec; 193(11):5733-43. PubMed ID: 25362181
[TBL] [Abstract][Full Text] [Related]
17. Selection of highly responsive T cell receptors by an analysis combining the expression of multiple markers.
Thi Viet Ha M; Hamana H; Shitaoka K; Hayee A; Kobayashi E; Yoshikawa T; Nakatsura T; Saikawa R; Sato E; Osawa M; Hitoshi Y; Son Dang T; Ozawa T; Kishi H
Cancer Sci; 2023 Jun; 114(6):2254-2264. PubMed ID: 36866942
[TBL] [Abstract][Full Text] [Related]
18. Antileukemia multifunctionality of CD4(+) T cells genetically engineered by HLA class I-restricted and WT1-specific T-cell receptor gene transfer.
Fujiwara H; Ochi T; Ochi F; Miyazaki Y; Asai H; Narita M; Okamoto S; Mineno J; Kuzushima K; Shiku H; Yasukawa M
Leukemia; 2015 Dec; 29(12):2393-401. PubMed ID: 26104661
[TBL] [Abstract][Full Text] [Related]
19. WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells.
Stauss HJ; Thomas S; Cesco-Gaspere M; Hart DP; Xue SA; Holler A; King J; Wright G; Perro M; Pospori C; Morris E
Blood Cells Mol Dis; 2008; 40(1):113-6. PubMed ID: 17855129
[TBL] [Abstract][Full Text] [Related]
20. Long-term phenotypic, functional and genetic stability of cancer-specific T-cell receptor (TCR) alphabeta genes transduced to CD8+ T cells.
Hiasa A; Hirayama M; Nishikawa H; Kitano S; Nukaya I; Yu SS; Mineno J; Kato I; Shiku H
Gene Ther; 2008 May; 15(9):695-9. PubMed ID: 18288212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]